Medicus Pharma To Discuss Positive Skinject(R) Phase 2 Topline Results In Fireside Chat Hosted By Brookline Capital Markets Biotechnology Equity Research Analyst

Go back to Medicus Pharma To Discuss Positive Skinject(R) Phase 2 Topline Results In Fireside Chat Hosted By Brookline Capital Markets Biotechnology Equity Research Analyst
(NASDAQ: MDCX) Delayed: 0.44 -0.02 (4.35%)
Previous Close $0.46    52 Week High
Open $0.46    52 Week Low
Day High $0.46    P/E N/A 
Day Low $0.40    EPS
Volume 2,154,228